The crystallographic form and morphology, resulting from the re-crystallisation of α-para 2 aminobenzoic acid (pABA) from mixed solutions of ethanol (EtOH) and nitromethane (NMe), is 3 reported. From solutions with compositions > 60 wt % NMe the α-polymorph of pABA appears. In 4 contrast, crystals prepared from mixed solvent with < 60 wt % NMe reveal the presence of a previously 5 unknown NMe solvate, which crystallises concomitantly with the α-structure, whose structure and 6 chemistry are presented here. 7
The NMe solvate crystal structure has similarities to α-pABA, in particular the existence of -OH…O-8 H-bonded dimers and NH…O H-bonds between pABA molecules, though the π-π stacking interactions 9 between the phenyl ring groups are found to be much more offset and do not form a continuous chain 10 through the structure, as found in α-pABA. The crystal structure is refined with a disordered NMe 11 molecule, with the hydrogen atoms, the nitrogen atom and one of the oxygen atoms being found in two 12
occupancies. The NMe is fond to primarily interact with the NH 2 group of pABA. Intermolecular 13 interactions within the solvate structure are generally weaker than those found in α-pABA and the 14 lattice energy is calculated to be significantly lower than α-pABA. This suggests that the solvate 15 structure is metastable with respect to α-pABA, and consistent with the observation that pure samples 16 of α-pABA are crystallised from solutions with >60% NMe content, which have longer induction times 17 and hence produce the more stable α-form. 18
The morphology of α-pABA crystals produced from solutions with increasing NMe content are found 19 to decrease in aspect ratio, in comparison to needle/lathe shaped crystals produced from pure EtOH. 20
Molecular modelling of the interactions between NMe, pABA molecules and crystal surfaces of α-21 pABA show that NMe has a greater propensity to interact with the NH 2 group and phenyl ring, in 22 comparison to the same calculations for EtOH, which indicate that it prefers to interact with the COOH 23 group. The data is consistent with NMe disrupting the π-π stacking interactions that dominate growth 24 along the needle (b-axis) direction of α-pABA, resulting in a more isotropic morphology. The 25 propensity of NMe to interact in this manner is also consistent with the formation of the solvate 26 structure, since NMe interacts with the slightly less tightly bound and coordinated NH 2 and phenyl 27 functional groups in α-pABA, in comparison to the COOH group which is more tightly bound to 28 surrounding pABA molecules. 29
The correlations between the structural features of α-pABA and the solvate, the molecular and surface 30 modelling and the experimental data provide a valuable insight into the effect of crystallisation solvent 31 on solvate formation and crystal morphology. This is highly relevant to the digital design of a 1 crystallisation process that can aid in the production of highly pure crystalline particles with tailored 2 physical properties. 3
Introduction

4
The demand for active pharmaceutical ingredients (API) to be crystallised with high purity and 5 desirable physical properties for downstream unit processes, has resulted in increased importance being 6 attributed to the crystallisation solvent selection process. This is in order to quantify the impact of 7 changes in solvent composition on the physical characteristics of the crystalline product, such as 8 propensity to form solvates [1] [2] [3] [4] [5] and variations in crystal morphology [6] [7] [8] [9] [10] [11] [12] [13] . Since a third of materials are 9 known to produce solvates 14 , a detailed understanding of polymorphism and solvate formation can be 10 vital in terms of consistent production of pure and stable drug products. As a caveat to this, the 11 avoidance of needle-like morphologies is also important in pharmaceutical and fine chemical product 12
processing, since they can create problems in downstream processing with their propensity to block 13 filters and pipes, along with their undesirable mechanical properties that can result in their breakage 14 during filtration 15 . Therefore, there is a need to correlate these material properties with molecular and 15 crystal structural packing features 1, 2, [16] [17] [18] , to design highly pure crystalline particles with pre-defined 16 physical properties. 17
Solvent screening can be a key step to assess the crystal form and morphology of APIs produced from 18 solution 19 , in order to ensure the stability of a drug product and avoid product failure, resulting in the 19 expensive process of product withdrawal and re-formulation 20 . Experimental screening can be 20 expensive and time-consuming, hence computational modelling can be used to guide the solvent 21 selection process for API crystallisation 2, 4, 5, 17, [21] [22] [23] [24] [25] [26] [27] [28] [29] . Once a stable solid form has been confirmed, the 22 crystallisation of this form with isotropic crystal morphology can often be desirable. Though the 23 crystallisation of more isotropic morphologies can sometimes be achieved through control of the solute 24 concentration (supersaturation) during solution crystallisation [30] [31] [32] , it can also be achieved by 25 manipulating the solvent composition [33] [34] [35] . Previous studies have demonstrated that an understanding of 26 the individual crystal surface chemistries, solvent physical properties and solution supersaturation can 27 result in more effective solvent or additive selection/design for tailoring the crystal growth and 28 morphology [36] [37] [38] [39] . Therefore, the ability to design crystallisation processes via solvent selection and/or 29 other control techniques is of significant importance to produce a stable solid form and desirable 30 crystalline physical properties. 31
Crystallising from a mixture of solvents with different properties can effectively alter the physical 1 properties (morphology, purity, crystallinity etc.) of a material demonstrated the applicability of using a computational approach to the design of a mixed solvation 5 environment that modified the needle-like morphology of 2,6-dihydroxy-benzoic acid. Such studies 6 have identified that understanding a solution crystallisation environment on the molecular level can 7 aide in rationalising the solution behaviour and physical properties of the crystals produced. 8 Drawing upon the above ideas, this study addresses the issue of solvent selection in the crystallisation 9 of p-amino benzoic acid (pABA), demonstrating firstly how the Cambridge Structural Database (CSD) 10 may be used as a tool for directing solvent choice, and secondly how state of the art synthonic 11 engineering tools 17, 43, 44 may be used to aid our understanding of how solvents control both the 12 morphology and phase of resulting solid forms. It is now well known that the α and β polymorphs of 13 pABA are enantiotropically related, having a transition temperature of ~ 14°C 45, 46 . It has also been 14 reported that only needle-like crystals of the high temperature stable α form appear from organic 15 solvents (eg alcohols, ethyl acetate, acetonitrile) regardless of the temperature 47, 48 . The more prismatic 16 β pABA only crystallises from water 17, 47, 49, 50 . The search for a new solvent was thus initially 17 motivated by the desire to crystallise the β polymorph directly from an organic solvent. As described 18 below, this search led to the use of nitromethane (NMe) and nitromethane/ethanol mixtures as the 19 crystallisation media 49 and ultimately to examine the solvent effect on crystalline phase and 20 morphology. The results are rationalised using molecular modelling of the solvent interaction with both 21 pABA molecules and crystal surfaces of α-pABA to attempt to understand, at the molecular level, the 22 observed crystalline structural form and morphology produced from the different solvent mixtures. 23
Materials and Methods
24
Materials 25
Ethanol was purchased from VWR chemicals having a purity of 99.9% (CAS: 64-17-5). Nitromethane 26 with > 99% purity was purchased from ACROS Organics (CAS: 75-52-5). The pABA was purchased 27 from Sigma Aldrich with 99% purity (CAS: 150-13-0). 28
Experimental Methods 29
Solubility Determination
Saturated solutions of α-pABA in pure EtOH, and EtOH:NMe mixtures (NMe concentration was 1 increased in 10 wt % steps all the way up to pure NMe) were prepared at the 10ml scale, agitated at the 2 desired temperature for 24 hours and allowed to settle for 12 hours, when the supernatant was pipetted 3 into a fresh sample vial and dried. The mass of solid was weighed using a 4-figure balance and the 4 mass checked over 3 days to ensure all solvent had evaporated. 5
van't Hoff Solubility Analysis 6
If a solution is assumed to be ideal, that is the solute/solute, solute/solvent and solvent/solvent 7 interactions are all equal, then the ideal solid/liquid equilibrium can be expressed, assuming a 8 negligible contribution from the heat capacity, as Equation (1) 9
where ܴ is the ideal gas constant, ‫ܪ∆‬ ௨௦ is the enthalpy of fusion, ܶ is the temperature and ܶ is the 11 melting temperature of α-pABA 51 . However, since most solutions are non-ideal, the van't Hoff 12 equation can be used to assess the degree of non-ideality, shown in Equation (2) 
Crystallisation Screening 22
The crystals were obtained from cooling crystallisation in EtOH:NMe solvent mixtures of 0% (by 23 weight) to 100% NMe content, at two supersaturations of S = 1.1 and S = 1.3. 10 g of solvent with the 24 appropriate amount α-pABA were agitated at 50ºC using a Julabo 53 F25 circulator for an hour to ensure 25 full dissolution of the solid. Then the agitation was halted and the solutions cooled to 10ºC and left to 26 crystallise, whereby crystallisation occurred within 5 days. Solutions were vacuum filtered to isolate 27 the solid crystalline form from the solution. 28
Crystals of the pure nitromethane solvate were prepared using slow solvent evaporation. 5 ml of pure 1 nitromethane was saturated with α-pABA at ambient temperature and pressure, this was then filtered 2 into a clean 10 ml screw cap vial and covered using plastic paraffin film with a single hole punctured 3 through using a clean needle. The solvent was allowed to evaporate slowly over 3 days; the resulting 4 crystals were isolated using vacuum filtration and air dried. 5
Crystal Morphology Characterisation 6
The crystals obtained were imaged by high quality photography using an Olympus Style TG4 camera. 7
Structural Characterisation 8
Powder X-ray diffraction (PXRD) of the samples was carried out using a Bruker D8 advanced X-ray 9 diffractometer, which used Cu Kα radiation and a germanium primary monochromator in a Bragg-10
Brentano reflection geometry. The step size used was 0.033 2θ, with a step time of 180 s/step over a 2θ 11 range of 5 -39.8° 2θ. The detector used was a Vantec-1 position sensitive detector. Samples were 12 prepared by grinding crystallisation products in a mortar and pestle and mounting on a flat plate sample 13 holder. Data reduction and Rietveld analysis were performed using PANalytical Highscore plus 14 software 54 . 15
For single X-ray diffraction, crystals were immersed in inert oil and mounted on a nylon loop. These 16 were then cooled to 100 K using an Oxford Cryosystems 700 Series Crysostream Cooler . Molecular graphics and tables of data were produced using Olex2
60
. 22
All non-hydrogen atoms were located in the Fourier Map and refined anisotropically. All hydrogen 23 atoms bound to carbon were placed in calculated positions and refined isotropically using a "riding 24 model". 25
2.3
Computational Methods 26
Overlaying of Molecular Structures 27
The molecular structures were overlaid using the 3-point fit module with Interchem 2013 61, 62 . 28
Synthon Characterisation
The strength and nature of the intermolecular interactions in the bulk crystal structure (intrinsic 1 synthons) were characterised using HABIT98 . 8
Molecular and Surface Grid-Based Searching 9
The most favoured binding sites between the solute and solvents were identified using the systematic 10 search program [71] [72] [73] . The program operates with a stationary and mobile phase, in this case they can be 11 single molecules or dimers so will simply be referred to as a 'body'. The stationary body is fixed, 12 whilst the mobile body moves around the stationary body on a grid. At each grid point, the mobile 13 phase can also rotate about three angles. At each point and rotation, the intermolecular energy was 14 calculated using the same potential parameters mentioned in Section 2.3.
15
In this study, the most favoured binding sites of up to 5 molecules of NMe and ethanol with a pABA 16 dimer were identified. The binding sites were searched sequentially. For the first simulation, the pABA 17 dimer was held rigid and the solvent molecule was moved around the grid surrounding the dimer and 18 the most favourable interaction between a solvent molecule and the dimer was identified. The 19 coordinates for the most favoured interaction between the pABA dimer and one solvent molecule was 20 used as the starting point for the second simulation, where it was held rigid and a second solvent 21 molecule was searched in the same way as the first simulation to find the most favoured binding site of 22 a second solvent molecule. This search procedure was repeated for up to 5 molecules of the solvent. 23
For the surface searching 74, 75 , a crystal surface, represented by a slab, was generated and the slab was 24 then treated as a fixed body during searching process. The thickness of the slab was selected to be a 25 multiple of the d-spacing (d hkl ) between adjacent (hkl) lattice planes, whilst the surface area was a 26 multiple of the crystal unit cell sizes. Therefore, the surface is embedded in an n 1 × n 2 × n 3 matrix to 27 eliminate the edge effects on the search results. The grid cells were generated based on three 28 orientations of the mobile body and two spherical polar angles between the two bodies, but only 29 covering half of the space facing the crystal surface, i.e., the azimuthal angle from 0 to 180 functionalities that could preferentially interact with the acid group of pABA. Accordingly the CSD 7 was searched for all crystal structures containing the pABA moiety. Excluding the 6 entries for pure 8 pABA and the structures in which pABA adopted the acid dimer, this amounted to 42 hits in which the 9 acid hydroxyl was bound to a non pABA group. Of these, 29 involved H-bonds directly to a nitrogen 10 (as pyridine, bipyridine, imidazole) and 13 were bound to oxygen either as carbonyl (6), water (2) or 11 nitro (5) functionality. On this basis, it was surmised that nitromethane would be an interesting solvent 12 to explore since it had not previously been chosen for crystallisation experiments. To our knowledge 13 this is the first report of the application of the CSD in solvent selection. 14 The data in Figure 1(b) shows that only the solubility up to about 30% NMe content was above the 6 ideal solubility line, consistent with the increase in solubility seen upon addition of small amounts of 7 NMe ( Figure S1(a), supplementary material) . It was also observed that the solubility at lower 8 temperatures was further above the ideal solubility than at higher temperatures, which suggests that 9 these liquids may be able to be significantly undercooled and remain stable 52 . The large errors observed 10 for the van't Hoff coordinates for pure NMe were due to the small amount of material produced from 11 Rietveld analysis, with pattern fitting to both the α-pABA and the solvate structure files. 3 together with the goodness of fit of the Rietveld refinement. *Solution did not crystallise over 5 5 days using the method described in section 2.2.3, hence the production of the pure NMe solid was 6 achieved using slow solvent evaporation in pure NMe 7 8 Table  9 1 10 shows 11 that in 12 general, the amount of solvate present in the samples is reduced with increasing NMe content, with a 13 maximum 80.1% of the solvate in the 10% NMe sample. It was observed that the samples with 40% 14 and 70-90% NMe content contained no evidence of the solvate structure. It was also observed that the 15 time taken to crystallise the solid increased with increasing NMe content in the solution. Therefore this 16
Solubility
suggests that the decrease in the amount of solvate structure with increasing NMe content could be 17 consistent with a meta-stablity of the solvate structure, i.e. with increased induction time to 18 crystallisation resulting in the more stable α-pABA structure. If the solvate phase was the more stable 19 phase, it would be expected that the increase of NMe content would enhance the crystallisation of the 20 solvate phase, however the fact that the solvent composition would impact on the transition 21 temperature between the two phases must also be considered. From the data collected it seems likely 22 that the α-phase is more stable than the solvate phase, and that nitromethane impacts on the relative 23 crystallisation rates of the two forms. 24
However, it should be highlighted that the 100% NMe sample included in Table 1 was produced from a 25 slow solvent evaporation experiment in pure NMe, which yielded a solid of the pure NMe solvate and a 26 separate solid which was a mixture of α-pABA and the NMe solvate. This therefore suggests that it 27 takes extremely careful control over the crystallisation conditions to produce a sample of the pure NMe 28 solvate structure. 29
It should also be mentioned that for the solubility measurements given in Figure 1 , the solid phase that 30 was harvested from the supernatant was assumed to be α-pABA. However, considering that it has now 31 been shown in Figures 2 and 3 phases can be obtained from the cooling crystallisation experiments in the EtOH:NMe solvent 1 mixtures. Therefore, it must be stated that the solubility measurements quoted here could be influenced 2 by the conversion of any of the material to the NMe solvate, and that currently the solubility of this 3 form is currently unknown. Hence, a future study that further examines the crystalline phase obtained 4 from the gravimetric analysis solubility measurements, along with identifying the solubility of the 5 solvate phase, could be of interest. 6
Solvate Crystal Structure and Chemistry
7
The unit cell and packing of the solvate crystal structure is shown in Figure 4 . Figure 4(a) shows that the solvent molecule with 54% occupancy was found to have both oxygens less 17 than 3 Å away from H11A on the amino group of pABA, whilst the NMe molecule was found to be 18 rotated in the 46% occupancy with O23B being found to be 4.8 Å away from H11A 19
It was observed in the PXRD patterns of the crystals produced from the different solvent mixtures that 20 some peaks were found to shift non-systematically in 2θ from sample to sample. This was attributed to 21 the disorder of the NMe in the structure, whereby the NMe could occupy the different atomic positions 22 identified from the single crystal structure, or even a mixture of the two (full details in supplementary 23 material). 24
The black lines in Figure 4 (c) and (d) highlight the existence of essentially identical H-bonded 25 tetramers, (two acid dimers linked by an NH…O hydrogen bond), which exist in both the solvate and 26 α-pABA structure. This would suggest that, analogous to the α-structure, that the OH…O H-bonding 27 dimers play a significant role in stabilising the crystal structure of the solvate. The orientations of the 28 two carboxylic acid H-bonding dimers within the two crystal structures are compared in Figure 5 . axis. In comparison, the stacking in the NMe solvate structure was found to be isolated interactions, 22 rather than a chain of π-π stacking. 23
The b-axis of the solvate structure was found to lengthen in comparison to the α-pABA structure. 24 (Figure 5(a) ) and the hydrogen bonds are directed approximately in the A and C directions, 2 hence they are approximately the same in length. In the solvate structure, the twisting of the dimers to 3 accommodate the NMe molecule has resulted in the dimers no longer being in the same plane running 4 along the a-axis, hence the a-axis has reduced (Figure 4(c) and (d)) . 5
The calculated strength of the intermolecular interactions (synthons) found within the NMe solvate is 6 shown in Table 2 , along with visualisation of the pairwise interactions. 7 The lattice energy calculated for the solvate structure was found to be almost 7 kcal/mol less than the 21 lattice energy calculated for α-pABA. Synthons A, B and C were found to be structurally similar to the 22 strongest synthons found in a study of the α-pABA crystal structure 17 , however they were in general 23 calculated to be weaker in the NMe solvate structure when compared to their counterparts in the α-24 pABA structure 17 . The significantly reduced calculated lattice energy, weaker synthons and decrease in 25 packing density (Table S2) crystallisation data in Section 3.3 Some extra hydrogen bonding interactions were also identified, an 1 NH…O H-bond between the pABA and NMe molecules and an NH…N H-bond between the pABA 2 molecules, which was not found to be present in the α-pABA structure 17 . The presence of the extra 3 hydrogen bonds probably somewhat compensates for the general weaker intermolecular synthonic 4 structure, hence stabilising the crystal structure. 5 NMe:EtOH ratio 21 22 Figure 6 shows that the crystals produced from solutions with increasing NMe content were found to 23 decrease in aspect ratio and become more opaque. Table 1 indicated that the crystals produced from 24 solutions with above 60% NMe content were pure α-pABA, therefore suggesting that the increasing 25
Crystal Morphologies from Mixed Solvents
NMe content reduces the aspect ratio of pure α-pABA crystals. Figure 6 also showed that the crystals 26 became more facetted and have smoother surfaces with increasing NMe content. Previous studies 27 suggested that the capping faces which terminate the b-axis of α-pABA grow by a rough interfacial 28 growth mechanism from ethanol 76 and that they are often not well formed upon solution 29 . Therefore, addition of NMe to the solutions appears to stabilise the interface and 1 encourage slower, stable growth of the α-pABA capping faces. 2 Figure 7 (a) shows that the EtOH molecules were found to prefer to bind to the COOH and NH 2 1 groups, whilst the NMe molecules were found to prefer to bind to the NH 2 group and the phenyl ring. 2
100%
Rationalisation of the Morphological and Structural Data through
This correlates to the orientation of the NMe molecule found within the solvate structure (Figure 4) . 3
This observation may be related to the maximum observed in the solubility dependence of pABA on 4
NMe content. This would imply that at a level of 10% NMe in EtOH both the phenyl ring and the 5 carboxylic acid group of pABA experience their maximum solvation. 6 Figure 7 (b) revealed that the vdW interactions had a relatively small contribution to the binding energy 7
for the EtOH molecule. However, after the addition of a fifth NMe molecule, the vdW contribution to 8 the energy started to increase strongly, consistent with the NMe molecule having a stronger interaction 9 with the phenyl ring. This is supported by Figure 7 (c), which shows that the systematic search 10 suggested that, in its most favourable position, the NMe molecule prefers to lie across the phenyl ring 11 at the capping face of α-pABA, whilst EtOH adopts a more orthogonal orientation in order to bind most 12 strongly to the COOH group. 13
It is interesting to comment that, as well as nitromethane, solvate structures have been produced from 14 acetone and dioxane . This observation could correlate with the fact that EtOH, which is 17 a polar and protic solvent, was found to prefer to strongly interact with the COOH group of pABA. The 18 COOH group forms several strong interactions with other pABA molecules in the α-pABA structure, 19 implying that there is probably not much space around this group. In contrast, the NH 2 and phenyl ring 20 groups probably have a greater amount of space around them in the structure, and the NMe molecule is 21 found to have a greater propensity to interact with those groups. Indeed, the NMe molecule is found to 22 be interacting primarily with the NH 2 group in the solvate structure. Hence, this implies that the space 23 around functional groups, along with the solvent/solute interactions with respect to these functional 24 groups, has a strong influence on the propensity of a particular solvent to produce a solvated crystalline 25 form. 26 We also suggest that the solute/solvent interactions in the crystal structure and calculated from the 27 molecular and surface systematic searches have implications with respect to the changes in crystal 28 morphology observed in Section 3.5. It has been observed that at the capping surface of α-pABA, the 29 pABA molecules integrate into the surface by forming π-π stacking interactions between the phenyl 30 ring structures 17 . Therefore the observation that the NMe molecule has a greater propensity to interact 31 with the phenyl ring, in comparison with ethanol, could imply that the presence of NMe results in the 1 observed reduction of the aspect ratio of crystals produced from solutions of increasing NMe 2 concentration. The surface search results shown in Figure 7 (c) suggest that, at the capping face, the 3 binding of the NMe could potentially hinder the formation of the chain of π-π stacking interactions that 4 are thought to strongly influence the needle-like morphology of α-pABA [16] [17] [18] 49 . This is supported by 5 the observation that such chains of close stacking phenyl rings in the pABA molecules, observed in the 6 α-pABA structure, were found to be absent in the solvate. 7 8
Conclusions 9
This study has demonstrated for the first time how a combined use of the CSD, crystal structure 10 analysis and molecular and crystal surface modelling of the solute-solvent interactions, can provide an 11 insight into the crystalline form and morphology produced from the different solvent mixtures. The 12 calculated propensity of NMe to interact more strongly with the NH 2 and phenyl ring groups, in 13 comparison to a polar protic solvent like EtOH which was calculated to prefer to interact with the 14 COOH group, probably resulted in the formation of the solvate structure, as there was space around the 15 NH 2 group for the NMe molecule to be accommodated. 16
The observed disorder of the NMe molecules in the solvate crystal structure accounted for the shifting 17 of the peaks in the PXRD, suggesting that the solvate structure could occupy different occupancies 18 when crystallised from solution. This correlated well to the calculated weaker synthonic interactions in 19 the solvate structure, in comparison to the α-structure, along with the observation that α-pABA 20 dominated the crystallisation from solutions with >60% NMe content, due to the increased 21 crystallisation time. 22
The greater propensity of the NMe molecule to interact strongly with the phenyl ring group of pABA, 23 along with the observed disruption in the π-π stacking interactions in the solvate structure, has been 24 correlated to the decrease in aspect ratio of crystals produced from solutions with increasing NMe 25 content. Since the π-π stacking interactions dominate the growth along the long axis of the needle, the 26 presence of NMe indicates its disruption to these interactions, hence slowing down the growth along 27 the long axis of the needle, producing the observed isotropic morphologies. 28
This work demonstrates how molecular and crystallographic modelling tools can be combined with in-29 depth particle analysis to explain the changes in physical properties of a crystalline material. This work 30
can assist in the on-going efforts to improve the digital design of crystallisation from solution, in 
